Monographie - Diazepam - Stabilis 4.0

最新更新 :
19/11/2024

Diazepam

化学構造

商品名

商品名、賦形剤は国、製薬会社ごとに異なることがあります

Ansiolin	イタリア
Bamyl	チリ
Compaz	ブラジル
Daiv	アルゼンチン, コロンビア
Diactal	アルゼンチン
Diapam	トルコ, フィンランド
Diazem	トルコ
Diazemuls	イギリス, イタリア, オランダ, カナダ
Diazep	ドイツ
Diazepam	アーストラリア, エクアドル, カナダ, コロンビア, ドイツ
Faustan	ドイツ
Gewalcalm	オーストリア
Kiatrium	ブラジル
Noan	イタリア
Normabel	クロアチア
Ortopsique	エクアドル
Pacitran	ペルー
Pax	南アフリカ共和国
Relanium	ポーランド
Rupediz	アルゼンチン
Stedon	ギリシア
Stesolid	アイスランド, サウジアラビア, スイス, スウェーデン, デンマーク, ドイツ, ノルウェー
Sunzepan	メキシコ
Tranject	南アフリカ共和国
Valium	アラブ首長国連邦, イタリア, エクアドル, エジプト, オランダ, オーストリア, コロンビア, サウジアラビア, スイス, スペイン, ドイツ, フランス, ブラジル, ベネズエラ, ベルギー, ポルトガル, メキシコ, モロッコ, ルクセンブルグ, 南アフリカ共和国

引用文献 : Diazepam

	形式	出版物
55	雑誌	Smith A, Bird G. The compatibility of diazepam with infusion fluids and their containers. J Clin Hosp Pharm 1982 ; 7: 181-186.
58	雑誌	Parker WA. Physical compatibility of ranitidine HCl with preoperative injectable medications. Can J Hosp Pharm 1985 ; 38: 160-161.
59	雑誌	Trissel LA, Gilbert DL, Martinez JF, Kim MC. Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
73	雑誌	Lor E, Takagi J. Visual compatibility of foscarnet with other injectable drugs. Am J Hosp Pharm 1990 ; 47: 157-159.
93	雑誌	Hutchings SR, Rusho WJ, Tyler LS. Compatibility of cefmetazole sodium with commonly used drugs during Y-site delivery. Am J Health-Syst Pharm 1996 ; 53: 2185-2188.
190	雑誌	Lee MG. Sorption of four drugs to polyvinyl chloride and polybutadiene intravenous administration sets. Am J Hosp Pharm 1986 ; 43: 1945-1950.
198	雑誌	Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520.
226	雑誌	Walker SE, DeAngelis C, Iazzetta J. Stability and compatibility of combinations of hydromorphone and a second drug. Can J Hosp Pharm 1991 ; 44: 289-295.
266	雑誌	Patel PR. Compatibility of meropenem with commonly used injectable drugs. Am J Health-Syst Pharm 1996 ; 53: 2853-2855.
299	雑誌	Trissel LA, Martinez JF, Gilbert DL. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
300	雑誌	Trissel LA, Gilbert DL, Martinez JF. Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
348	雑誌	Hancock BG, Black CD. Effect of a polyethylene-lined administration set on the avaibility of diazepam injection. Am J Hosp Pharm 1985 ; 42: 335-339.
350	雑誌	Martens HJ, De Goede PN, Van Loenen AC. Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers. Am J Hosp Pharm 1990 ; 47: 369-373.
351	雑誌	Yliruusi JK, Uotila JA, Kristoffersson ER. Effect of flow rate and type of IV container on adsorption of diazepam to IV administration systems. Am J Hosp Pharm 1986 ; 43: 2795-2799.
352	雑誌	Yliruusi JK, Uotilo JA, Kristoffersson ER. Effect of tubing length on adsorption of diazepam to polyvinyl chloride administration sets. Am J Hosp Pharm 1986 ; 43: 2789-2794.
402	雑誌	Savitsky ME. Visual compatibility of neuromuscular blocking agents with various injectable drugs during simulated Y-site injection. Am J Hosp Pharm 1990 ; 47: 820-821.
476	雑誌	Knapp AJ, Mauro VF, Alexander KS. Incompatibility of ketorolac tromethamine with selected postoperative drugs. Am J Hosp Pharm 1992 ; 49: 2960-2962.
496	雑誌	Lor E, Sheybani T, Takagi J. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1991 ; 48: 744-746.
616	雑誌	Jump WG, Plaza VM, Poremba A. Compatibility of nalbuphine hydrochloride with other preoperative medications. Am J Hosp Pharm 1982 ; 39: 841-843.
621	雑誌	Yliruusi JK, Sothmann AG, Laine RH, Rajasilta RA, Kristoffersson ER. Sorptive loss of diazepam and nitroglycerin from solutions to three types of containers. Am J Hosp Pharm 1982 ; 39: 1018-1021.
660	雑誌	Michaels MR, Stauffer GL, Haas DP. Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility. Ann Pharmacotherapy 1996 ; 30: 228-232.
711	雑誌	Cloyd JC, Vezeau C, Miller KW. Avaibility of diazepam from plastic containers. Am J Hosp Pharm 1980 ; 37: 492-496.
712	雑誌	Parker WA, MacCara ME. Compatibility of diazepam with intravenous fluid containers and administration sets. Am J Hosp Pharm 1980 ; 37: 496-500.
730	雑誌	Allen LV, Saul Levinson R, Phisutsinthop D. Compatibility of various admixtures with secondary additives at Y-injection site of intravenous administration sets. Am J Hosp Pharm 1977 ; 34: 939-943.
731	雑誌	Morris ME. Compatibility and stability of diazepam injection following dilution with intravenous fluids. Am J Hosp Pharm 1978 ; 35: 669-672.
921	雑誌	Trissel LA, Gilbert DL, Martinez JF. Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration. Hosp Pharm 1998 ; 33: 284-292.
939	雑誌	Gilbar PJ, Groves CF. Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection. Aust J Hosp Pharm 1994 ; 24: 167-170.
1041	雑誌	Hasegawa GR, Eder JF. Visual compatibility of dobutamine hydrochloride with other injectable drugs. Am J Hosp Pharm 1984 ; 41: 949-951.
1057	雑誌	Cutie MR. Compatibility of verapamil hydrochloride injection with commonly used additives. Am J Hosp Pharm 1983 ; 40: 1205-1207.
1067	雑誌	Zeidler C, Dettmering D, Schrammel W, Spieteller M. Compatibility of various drugs used in intensive care medicine in polyethylene, PVC and glass infusion containers. EJHP 1999 ; 5: 106-110.
1102	雑誌	Cossum PA, Roberts MS. Availability of isosorbide dinitrate, diazepam and chlormethiazole, from i.v. delivery systems. Eur J Clin Pharmacol 1981 ; 19: 181-185.
1173	雑誌	Kowaluk EA, Roberts MS, Blackburn HD, Polack AE. Interactions between drugs and polyvinyl chloride infusion bags. Am J Hosp Pharm 1981 ; 38: 1308-1314.
1182	雑誌	Mason NA, Cline S, Hyneck ML, Berardi RR, Ho NFH, Flynn GL. Factors affecting diazepam infusion: solubility, administration-set composition, and flow rate. Am J Hosp Pharm 1981 ; 38: 1449-1454.
1199	雑誌	Smith FM, Nuessle NO. Stability of diazepam injection repackaged in glass unit-dose syringes. Am J Hosp Pharm 1982 ; 1687-1690.
1200	雑誌	Chaudry IA, Bruey KP, Hurlburt LE, Oden EM. Compatibility of netilmycin sulfate injection with commonly used intravenous injections and additives. Am J Hosp Pharm 1981 ; 38: 1737-1742.
1232	雑誌	Beatson C, Taylor A. A physical compatibility study of furosemide & flucloxacillin injections. Br J Pharm Pract 1987 ; 9: 223-226, 236.
1269	雑誌	DeMuynck C, De Vroe C, Remon JP, Colardyn F. Binding of drugs to end-line filters: a study of four commonly administered drugs in intensive care units. J Clin Pharm Ther 1988 ; 13: 335-340.
1271	雑誌	Mathot F, Bonnard J, Paris P, Bosly J. Reliable continuous IV perfusion system for diazepam. J Pharm Belg 1982 ; 37: 153-156.
1366	雑誌	Jeglum EL, Winter E, Kotos M. Nafcillin sodium incompatibility with acidic solutions. Am J Hosp Pharm 1981 ; 38: 462,464.
1424	雑誌	Gottwald MD, Akerd LC, Liu PK, Orsulak PJ, Corry M, Bacchetti P, Fields SM, Loxenstein DH, Alldredge BK. Prehospital stability of diazepam and lorazepam. Am J Emerg Med 1999 ; 17: 333-337.
1438	雑誌	Souney PF, Solomon MA, Stancher D. Visual compatibility of cimetidine hydrochloride wih common preoperative injectable medications. Am J Hosp Pharm 1984 ; 41: 1840-1841.
1472	雑誌	Salomies HEM, Heinonen RM, Toppila MAI. Sorptive loss of diazepam, nitroglycerin and warfarin sodium to polypropylene-lined infusion bags (Softbags). Int J Pharm 1994 ; 110: 197-201.
1512	実験	Tirofiban (Aggrastat®) - Summary of Product Characteristics Beacon Pharmaceuticals Ltd 2015
1522	実験	Macoflex N® Maco Pharma 2001
1603	雑誌	Bergquist PA, Manas D, Hunke WA, Reed RA. Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs. Am J Health-Syst Pharm 2001 ; 58: 1218-1223.
1625	雑誌	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1662	雑誌	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1712	雑誌	Trissel LA, Saenz CA. Compatibility screening of Precedex during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 230-233.
1713	雑誌	Trissel LA, Saenz CA. Compatibility screening of bivalirudin during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 311-315.
1721	雑誌	Trissel LA, Williams KY, Baker MB. Compatibility screening of Hextend during simulated Y-site administration with other drugs. Int J Pharm Compound 2001 ; 5: 69-72.
1803	雑誌	Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB. Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2003 ; 60: 80-85.
1925	雑誌	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
1960	雑誌	Kambia NK, Dine T, Dupin-Spriet T, Gressier B, Luycks M, Goudaliez F, Brunet C. Compatibility of nitroglycerin, diazepam and chlorpromazine with a new multilayer material for infusion containers. J Pharm Biomed Anal 2005 ; 37: 259-264.
1974	雑誌	Chandler SW, Trissel LA, Weinstein SM Combined administration of opoids with selected drugs to manage pain and other cancer symptoms initial safety screening for compatibility. J Pain Symptom Manage 1996 ; 12, 3: 168-171.
2087	雑誌	Ferreira E, Forest JM, Hildgen P. Compatibility of dimenhydrinate injectable by Y administration. Pharmactuel 2004 ; 37: 17-20.
2090	雑誌	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
2262	雑誌	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2269	雑誌	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
2324	雑誌	Treleano A, Wolz G, Brandsch R, Welle F. Investigation into the sorption of nitroglycerin and diazepam into PVC tubes and alternative tube materials during application Int J Pharm 2009 ; 369, 1-2 : 30-37
3012	雑誌	Sullivan T, Forrest J.M, Leclair G. Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration Hosp Pharm 2015 ; 50, 3: 214-220.
3184	実験	Hyaluronidase (Hyalase®) - Summary of Product characteristics. CP Pharmaceuticals 2005
3216	雑誌	Legris ME, Valiquette ME, Lavoie A, Forest JM, Leclair G. Compatibilité physique par évaluation visuelle du salbutamol injectable lors de son administration en Y. Pharmactuel 2011 ; 44, 1 : 14-18
3249	雑誌	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3332	実験	Tigecycline (Tigacyl®) - Summary of Product characteristics Pfizer 2012
3408	雑誌	Tollec S, Touzin K, Pelletier E, Forest J.M. Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels. Pharmactuel 2013 ; 46, 1 : 16-21.
3474	実験	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3501	実験	Ketamine hydrochloride (Ketalar®) - Summary of Product Characteristics Pfizer 2011
3521	実験	Tramadol® - Summary of Product Characteristics. Beacon Pharmaceuticals 2012
3539	実験	Bivalirudin (Angiox®) - Summary of Product Characteristics. The Medecines Company 2013
3540	実験	Heparin sodium - Summary of Product Characteristics. Wockhardt 2010
3560	実験	Linezolid (Zyvox®) - Summary of Product Characteristics Pharmacia 2013
3564	実験	Rocuronium B Braun - Résumé des caractéristiques du produit. B Braun 2012
3571	雑誌	Anderson C, Boehme S, Ouellette J, Stidham C, MacKay M. Physical and Chemical Compatibility of Injectable Acetaminophen During Simulated Y-Site Administration. Hosp Pharm 2014 ; 49, 1: 42-47.
3599	実験	Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics Amco Amdipharm Mercry 2013
3607	実験	Esmolol hydrochloride for injection - Summary of Product Characteristics AOP Orphan Pharmaceuticals AG 2013
3614	実験	Nicardipine Injection - Summary of Product Characteristics American Regent Inc 2013
3617	実験	Hyaluronidase (Hyalase®) - Summary of Product Characteristics Wockhardt 2011
3672	実験	Nalbuphine Mylan - Résumé des caractéristiques du produit Mylan SAS 2016
3766	雑誌	Forrest J.M, Hildgen P. Compatibilité de l’acétylcystéine injectable lors de son administration en Y avec d’autres médicaments usuels Pharmactuel 2014 ; 47, 3 : 161-165.
3767	雑誌	Legris M.E, Lavoie A, Forrest J.M, Hildgen P. Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels. Pharmactuel 2014 ; 47, 3 : 167-172.
3824	雑誌	Boudi S, Roy H, Forest JM, Leclair G. Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y. Pharmactuel 2023 2023;56,3:91-98
3885	雑誌	Su-Eon Jin, Siwon You, Seungho Jeon, Sung-Joo Hwang. Diazepam sorption to PVC- and non-PVC-based tubes in administration sets with quantitative determination using a high-performance liquid chromatographic method. Int J Pharm 2016 ; 506 : 414-419.
3932	実験	Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit Serb Laboratoire 2015
3941	実験	Nicardipine - Summary of Product Characteristics Concordia International 2017
3964	雑誌	Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G. Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments. Pharmactuel 2017 ; 50,1 : 27-33.
4154	実験	Bleomycin sulfate- Summary of Product Characteristics Accord Health Care 2018
4319	雑誌	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4428	雑誌	Rashed S.M, Sweatman T.W, Thoma L, Hovinga C.A, Phelps S.J. Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma. J Pediatr Pharmacol Ther 2004 ; 9, 2: 126-132.
4435	雑誌	Hanifah S, Nugroho B.H, Chabib L. Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection. Anaesthesiol Intensive Ther 2020 ; 52, 1: 23-27.
4603	雑誌	Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G. Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Hosp Pharm 2021 ; 56, 4: 228-234.
4650	実験	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 2021
4700	実験	Esketamine 25 mg/mL solution for injection/infusion. - Summary of Product Characteristics AS Kalceks 2022
4742	雑誌	Macoviciuc M, Nguyen C, Forest J-M, Leclair G. Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y. Pharmactuel 2022 ; 55, 4: 247-255.

Mentions Légales